Essential roles of sphingosine-1-phosphate and platelet-derived growth factor in the maintenance of human embryonic stem cells

被引:128
作者
Pébay, A
Wong, RCB
Pitson, SM
Wolvetang, EJ
Peh, GSL
Filipczyk, A
Koh, KLL
Tellis, I
Nguyen, LTV
Pera, MF
机构
[1] Monash Univ, Australian Stem Cell Ctr, Monash Inst Med Res, Lab Embryon Stem Cell Biol,STRIP, Clayton, Vic 3800, Australia
[2] Inst Med & Vet Sci, Hanson Inst, Div Human Immunol, Adelaide, SA 5000, Australia
关键词
human embryonic stem cells; sphingosine-1-phosphate; platelet-derived growth factor; lysophosphatidic acid;
D O I
10.1634/stemcells.2004-0338
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Human embryonic stem cells (hESCs) have great potential for use in research and regenerative medicine, but very little is known about the factors that maintain these cells in the pluripotent state. We investigated the role of three major mitogenic agents present in serum-sphingosine-l-phosphate (SIP), lysophosphatidic acid (LPA), and platelet-derived growth factor (PDGF)-in maintaining hESCs. We show here that although LPA does not affect hESC growth or differentiation, coincubation of SIP and PDGF in a serum-free culture medium successfully maintains hESCs in an undifferentiated state. Our studies indicate that signaling pathways activated by tyrosine kinase receptors act synergistically with those downstream from lysophospholipid receptors to maintain hESCs in the undifferentiated state. This study is the first demonstration of a role for lysophospholipid receptor signaling in the maintenance of stem cell pluripotentiality. STEM C ELLS 2005;23:1541-1548.
引用
收藏
页码:1541 / 1548
页数:8
相关论文
共 36 条
[1]   Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture [J].
Amit, M ;
Carpenter, MK ;
Inokuma, MS ;
Chiu, CP ;
Harris, CP ;
Waknitz, MA ;
Itskovitz-Eldor, J ;
Thomson, JA .
DEVELOPMENTAL BIOLOGY, 2000, 227 (02) :271-278
[2]   Feeder layer- and serum-free culture of human embryonic stem cells [J].
Amit, M ;
Shariki, C ;
Margulets, V ;
Itskovitz-Eldor, J .
BIOLOGY OF REPRODUCTION, 2004, 70 (03) :837-845
[3]  
Andrews PW, 1996, INT J CANCER, V66, P806, DOI 10.1002/(SICI)1097-0215(19960611)66:6<806::AID-IJC17>3.0.CO
[4]  
2-0
[5]  
Badcock G, 1999, CANCER RES, V59, P4715
[6]   Cell adhesion regulates ubiquitin-mediated degradation of the platelet-derived growth factor receptor β [J].
Baron, V ;
Schwartz, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (50) :39318-39323
[7]   Expression of platelet-derived growth factor-A (PDGF-A), PDGF-B, and PDGF receptor-α and -β during human testicular development and disease [J].
Basciani, S ;
Mariani, S ;
Arizzi, M ;
Ulisse, S ;
Rucci, N ;
Jannini, EA ;
Della Rocca, C ;
Manicone, A ;
Carani, C ;
Spera, G ;
Gnessi, L .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (05) :2310-2319
[8]   Activin A maintains pluripotency of human embryonic stem cells in the absence of feeder layers [J].
Beattie, GM ;
Lopez, AD ;
Bucay, N ;
Hinton, A ;
Firpo, MT ;
King, CC ;
Hayek, A .
STEM CELLS, 2005, 23 (04) :489-495
[9]   International Union of Pharmacology. XXXIV. Lysophospholipid receptor nomenclature [J].
Chun, J ;
Goetzl, EJ ;
Hla, T ;
Igarashi, Y ;
Lynch, KR ;
Moolenaar, W ;
Pyne, S ;
Tigyi, G .
PHARMACOLOGICAL REVIEWS, 2002, 54 (02) :265-269
[10]   A NOVEL KERATAN SULFATE PROTEOGLYCAN FROM A HUMAN EMBRYONAL CARCINOMA CELL-LINE [J].
COOPER, S ;
PERA, MF ;
BENNETT, W ;
FINCH, JT .
BIOCHEMICAL JOURNAL, 1992, 286 :959-966